Besponsa 1mg Injection 1s

In Acute lymphoblastic leukemia : Blood cancer, also called leukemia, is a cancer of the blood-forming tissues that decreases the body's ability to fight infection. Besponsa 1mg Injection kills or stops the growth of cancer cells and prevents the multiplication of cancer cells. It is a potent and very toxic medicine, and you should discuss its risks and benefits with your doctor. Avoid drinking alcohol during the treatment with this drug and drink plenty of water to stay hydrated.In Acute lymphoblastic leukemia : Blood cancer, also called leukemia, is a cancer of the blood-forming tissues that decreases the body's ability to fight infection. Besponsa 1mg Injection kills or stops the growth of cancer cells and prevents the multiplication of cancer cells. It is a potent and very toxic medicine, and you should discuss its risks and benefits with your doctor. Avoid drinking alcohol during the treatment with this drug and drink plenty of water to stay hydrated.

The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.

Your doctor or nurse will give you this medicine. Kindly do not self administer.Your doctor or nurse will give you this medicine. Kindly do not self administer.

Besponsa 1mg Injection contains Inotuzumab Ozogamicin, an antineoplastic agent that treats relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL) in adults. targets CD22 antigen expressed on immature B-cell lymphocytes and blocks further growth of tumor cells. This medicine restores normal blood counts and helps achieve complete remission from the disease.Besponsa 1mg Injection contains Inotuzumab Ozogamicin, an antineoplastic agent that treats relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL) in adults. targets CD22 antigen expressed on immature B-cell lymphocytes and blocks further growth of tumor cells. This medicine restores normal blood counts and helps achieve complete remission from the disease.

The Capital, 1802, 18th Floor , Plot No. C-70, Block , Bandra Kurla Complex, Bandra East , Mumbai 400051.